Skip to content

Edentulous Sites Augmented With Collagen Matrix or CTG

Volumetric Changes at Edentulous Sites Augmented With Collagen Matrix or Connective Tissue Graft: a Randomized Clinical Trial With 6 Months Follow up

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04915677
Enrollment
28
Registered
2021-06-07
Start date
2021-06-10
Completion date
2024-03-10
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edentulous Alveolar Ridge

Brief summary

Ridge deformities can complicate prosthetic rehabilitation, especially in situations where optimal esthetic outcomes are desired. Simpler, less invasive and predictable treatments are needed in order to obtain soft tissue augmentation at edentulous ridges. Autogenous subepithelial connective tissue graft (SCTG) has always been regarded as the treatment of choice, but heterologous volume stable collagen matrix (VCMX) is emerging as a reliable alternative. The principal aim of the present RCT will be to compare the volumetric buccal soft tissue changes at edentulous areas after augmentation procedure using VCMX or SCTG. Parameters related to periodontal health at adjacent teeth and patient reported outcomes (PROMs) will be also assessed as secondary outcomes. Proving the non- inferiority of VCMX compared to SCTG would provide the specialists and general clinicians with an easier, less invasive and better tolerated technique for soft tissue augmentation at edentulous ridges and for improving aesthetic and cleansability of the prosthetic rehabilitation.

Interventions

After local anesthesia a mesio-distal crestal incision will be performed reaching the alveolar bone. Split thickness dissection performed both buccal and palatal. Subepithelial connective tissue graft will be harvested and inserted beneath the mucoperiosteal flap and stretched buccally and lingually using a modified horizontal mattress suture. The flap margins at the crest will be adapted using single interrupted sutures in order to achieve a primary closure of the flap.

PROCEDURESoft tissue augmentation with xenogenic volume stable collagen matrix

After local anesthesia a mesio-distal crestal incision will be performed reaching the alveolar bone. Split thickness dissection performed both buccal and palatal. Xenogenic volume stable collagen matrix will be inserted beneath the mucoperiosteal flap and stretched buccally and lingually using a modified horizontal mattress suture. The flap margins at the crest will be adapted using single interrupted sutures in order to achieve a primary closure of the flap.

Sponsors

University of Turin, Italy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Intercalated mono-edentulous area ridge defects to be rehabilitated with fixed partial bridge * At least 18 years old * At least 6 months from tooth extraction at the study area.

Exclusion criteria

* Systemic diseases which could influence the outcome of the therapy (e.g. uncontrolled diabetes mellitus); * Smoking ≥ 10 cigarettes a day; * Pregnant or nursing women; * Chronic use of corticosteroids or other anti-inflammatory or immune-modulator drugs; * Patients who need use of medications affecting bone metabolism or oral mucosa; * Presence of a congruous FDP at the edentulous area; * History of soft tissue augmentation surgery in the study area; * Active periodontitis * Uncompliant patients

Design outcomes

Primary

MeasureTime frameDescription
Volumetric buccal soft tissue changes (-5 to +5 mm with positive values representing an increase in volume)6 monthsMean linear change in mm from baseline to 6 months follow-up

Secondary

MeasureTime frameDescription
Change in Probing Pocket Depth (PD) at adjacent teeth (0-15 mm with higher values representing worse outcomes)6 monthsThe distance between cementoenamel junction (CEJ) and the base of the pocket
Mucosal recession at adjacent sites (0-15 mm with higher values indicating worse outcomes)6 monthsThe distance between the cementoenamel junction (CEJ) and the mucosal margin
Pain (VAS scale)(0-10 with higher values indicating worse outcomes)2 weeksSubjective pain experienced by the patient expressed in a VAS scale

Countries

Italy

Contacts

Primary ContactMario Aimetti
mario.aimetti@unito.it00390116331546

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026